These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8332249)

  • 1. Indirect serotonergic agonists attenuate neuronal opiate withdrawal.
    Akaoka H; Aston-Jones G
    Neuroscience; 1993 Jun; 54(3):561-5. PubMed ID: 8332249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local opiate withdrawal in locus coeruleus neurons in vitro.
    Ivanov A; Aston-Jones G
    J Neurophysiol; 2001 Jun; 85(6):2388-97. PubMed ID: 11387385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat.
    Taylor JR; Punch LJ; Elsworth JD
    Psychopharmacology (Berl); 1998 Jul; 138(2):133-42. PubMed ID: 9718282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
    Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
    J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus.
    Hong M; Milne B; Jhamandas K
    Brain Res; 1993 Sep; 623(1):131-41. PubMed ID: 8221081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
    Vandergriff J; Rasmussen K
    Neuropharmacology; 1999 Feb; 38(2):217-22. PubMed ID: 10218862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input.
    Akaoka H; Aston-Jones G
    J Neurosci; 1991 Dec; 11(12):3830-9. PubMed ID: 1683899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of withdrawal-induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine-dependent rats.
    Pineda J; Torrecilla M; Martín-Ruiz R; Ugedo L
    Neuropharmacology; 1998 Jun; 37(6):759-67. PubMed ID: 9707290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal.
    Taylor JR; Elsworth JD; Garcia EJ; Grant SJ; Roth RH; Redmond DE
    Psychopharmacology (Berl); 1988; 96(1):121-34. PubMed ID: 3147472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine.
    Britton KT; Svensson T; Schwartz J; Bloom FE; Koob GF
    Life Sci; 1984 Jan; 34(2):133-9. PubMed ID: 6537983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locus coeruleus neurons from morphine-treated rats do not show opiate-withdrawal hyperactivity in vitro.
    Bell JA; Grant SJ
    Brain Res; 1998 Mar; 788(1-2):237-44. PubMed ID: 9555033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Afferent effects on locus coeruleus in opiate withdrawal.
    Rasmussen K
    Prog Brain Res; 1991; 88():207-16. PubMed ID: 1839935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus.
    Medrano MC; Mendiguren A; Pineda J
    Psychopharmacology (Berl); 2015 Aug; 232(15):2795-809. PubMed ID: 25787747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray.
    Punch LJ; Self DW; Nestler EJ; Taylor JR
    J Neurosci; 1997 Nov; 17(21):8520-7. PubMed ID: 9334424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavior of monkeys during opiate withdrawal and locus coeruleus stimulation.
    Grant SJ; Huang YH; Redmond DE
    Pharmacol Biochem Behav; 1988 May; 30(1):13-9. PubMed ID: 3174735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of inhibitory synaptic currents of locus coeruleus neurons via orexin type 1 receptors in the context of naloxone-induced morphine withdrawal.
    Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
    J Physiol Sci; 2019 Mar; 69(2):281-293. PubMed ID: 30406600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local opiate withdrawal in locus coeruleus in vivo.
    Aston-Jones G; Hirata H; Akaoka H
    Brain Res; 1997 Aug; 765(2):331-6. PubMed ID: 9313908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
    Caillé S; Espejo EF; Koob GF; Stinus L
    Pharmacol Biochem Behav; 2002 Jul; 72(4):979-86. PubMed ID: 12062589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective mGlu2/3 receptor antagonist LY341495 exacerbates behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons.
    Rasmussen K; Hsu MA; Vandergriff J
    Neuropharmacology; 2004 Apr; 46(5):620-8. PubMed ID: 14996539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates.
    Rasmussen K; Beitner-Johnson DB; Krystal JH; Aghajanian GK; Nestler EJ
    J Neurosci; 1990 Jul; 10(7):2308-17. PubMed ID: 2115910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.